DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Raptiva (Efalizumab) - Squamous Cell Carcinoma - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Squamous Cell Carcinoma (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Raptiva (Efalizumab) where reactions include squamous cell carcinoma. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Raptiva side effects in 53 year old male

Reported by a physician from Finland on 2012-01-23

Patient: 53 year old male

Reactions: Lymphadenopathy, Squamous Cell Carcinoma, Tongue Neoplasm Malignant Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Raptiva
    Dosage: 1 dose weekly
    Indication: Psoriasis
    Start date: 2006-11-09
    End date: 2007-06-01

Enbrel
    Dosage: 50 mg, weekly
    Indication: Psoriasis
    Start date: 2007-07-01

Enbrel
    Indication: Psoriatic Arthropathy

Other drugs received by patient: Emconcor Comp; Betamethasone Dipropionate / Calcipotriol; Diapam / 00017001 /



Possible Raptiva side effects in 53 year old male

Reported by a physician from Finland on 2011-12-26

Patient: 53 year old male

Reactions: Lymphadenopathy, Squamous Cell Carcinoma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Raptiva
    Dosage: unk unk, qwk
    Indication: Psoriasis
    Start date: 2006-11-09
    End date: 2007-06-01

Enbrel
    Dosage: 50 mg, weekly
    Indication: Psoriasis
    Start date: 2007-07-01

Other drugs received by patient: Emconcor Comp; Betamethasone Dipropionate / Calcipotriol; Diapam / 00017001 /

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017